These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2849786)

  • 1. Immunological characteristics and potential approaches to immunotherapy of HIV infection.
    Hersh EM; Petersen EA; Yocum DE; Gorman SR; Darragh MJ; Gschwind CR; Brewton GW; Reuben JA
    Recent Results Cancer Res; 1988; 112():17-26. PubMed ID: 2849786
    [No Abstract]   [Full Text] [Related]  

  • 2. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive therapy with purified CD8 cells in HIV infection.
    Herberman RB
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):35-40. PubMed ID: 1535457
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic alterations in human immunodeficiency virus infection: a review.
    de Martini RM; Parker JW
    J Clin Lab Anal; 1989; 3(1):56-70. PubMed ID: 2654343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunomodulating treatment of patients with HIV infection].
    Skotnicki AB; Kornaszewski W
    Przegl Dermatol; 1989; 76(4):285-91. PubMed ID: 2483589
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of immune reactivity to self.
    Cruse JM; Lewis RE
    Concepts Immunopathol; 1987; 4():1-23. PubMed ID: 3297330
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of immunotherapy in the treatment of HIV.
    Saag MS
    AIDS; 2001 Feb; 15 Suppl 2():S1-3. PubMed ID: 11424970
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in the therapy of HIV infection.
    Yarchoan R; Mitsuya H; Broder S
    Immunol Today; 1993 Jun; 14(6):303-9. PubMed ID: 8397771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation in HIV-1 infection in the HAART era.
    Imami N; Sullivan AK; Gotch FM
    J HIV Ther; 2001 Nov; 6(4):77-84. PubMed ID: 11740408
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status and future prospects in the immunotherapy of human immunodeficiency virus (HIV) infection.
    Hadden JW
    Adv Exp Med Biol; 1993; 335():203-10. PubMed ID: 8237596
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin 2 therapy in infectious diseases: rationale and prospects.
    Siegel JP; Rook AH; Djeu JY; Quinnan GV
    Infection; 1984; 12(4):298-302. PubMed ID: 6092280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring vaccine-induced HIV neutralization: report of a workshop.
    Hanson CV
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):645-8. PubMed ID: 8074928
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive immunotherapy in treatment of advanced human immunodeficiency virus infection.
    Karpas A
    J Infect Dis; 1994 Sep; 170(3):742-4. PubMed ID: 8077741
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-based immunotherapy for human immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Dropulic B; June CH
    Hum Gene Ther; 2006 Jun; 17(6):577-88. PubMed ID: 16776567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New frontiers of immunotherapy for HIV.
    Haynes BF
    Lancet; 1996 Dec; 348(9041):1531-2. PubMed ID: 8950876
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic perspectives in human immunodeficiency virus infection.
    Schooley RT; Blumberg RS; Vogt M; Hartshorn K; Hirsch MS
    J Exp Pathol; 1987; 3(4):661-80. PubMed ID: 3331652
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotherapy of AIDS.
    Biotherapy; 1990; 2(2):103-81. PubMed ID: 2400631
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation of natural cytotoxicity by leucine enkephalin in cultured peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
    Oleson D; Grierson H; Goldsmith J; Purtilo DT; Johnson D
    Clin Immunol Immunopathol; 1989 Jun; 51(3):386-95. PubMed ID: 2721034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma immunotherapy in a child with acquired immunodeficiency syndrome.
    Wong VK; Gillette SG; Roth MJ; Miles S; Stiehm ER
    Pediatr Infect Dis J; 1993 Nov; 12(11):947-51. PubMed ID: 8265287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.